vaccine efficacy in children is over 90%

October 22, 2021 4:11 pm

The serum is already authorized for anyone aged 12 or over: US regulatory bodies are evaluating the extension for the 5-11 year range

Pfizer’s full-dose vials are already licensed for anyone 12 or older, but pediatricians and many parents are eagerly awaiting protection for younger children to stem the increase in Delta variant infections and ensure that the children manage to stay in school.


With third dose, 95.6% efficacy of the vaccine

Pfizer and BioNTech, meanwhile, have announced the results of a phase 3 study that evaluates the efficacy and safety of a booster dose of the vaccine in over 10,000 individuals aged 16 and over. The relative effectiveness of the vaccine after the booster, the two companies say, is 95.6% against the disease, in a situation where the Delta variant is the prevailing strain.

In the trial, the booster was given to people who had received the two-dose primary series of the same vaccine. And the third injection “restored the protection of the vaccine against Covid to the high levels reached after the second dose”, assured the American Pfizer and the German BioNTech, “showing a relative vaccine efficacy of 95.6%, compared to those who have not received a recall. “


vaccine efficacy children

PREV Delia Duran “Kiss between Alex and Soleil? Without words” / Guenda Goria blurts out “He’s in crisis”
NEXT Do you wash yourself with a bath sponge? Wrong: it is dangerous